Journal of Pharmaceutical Care & Health Systems
Open Access
ISSN: 2376-0419
+44 1300 500008
ISSN: 2376-0419
+44 1300 500008
Masami Tanaka, Takeshi Nishimura, RisaSekioka and Hiroshi Itoh
Keio University School of Medicine, Japan
Scientific Tracks Abstracts: J Pharma Care Health Sys
There have been several reports demonstrating that type 2 diabetic patients with high serum total bilirubin concentration (TBC) tend to be less complicated with diabetic retinopathy. Although this observation might suggest a protective role of bilirubin against diabetic retinopathy, the precise relationship between bilirubin and retinopathy, such as the severity of retinopathy, is not known yet. Therefore, we studied the relationship between the severities of diabetic retinopathy and serum TBC. In addition, we compared the importance of bilirubin with the factors which were shown to be associated with the incidence of diabetic retinopathy in Japan. In this retrospective study, a total of 674 patients with type 2 diabetes were included. Serum TBCs were compared between patients with and without diabetic retinopathy, and according to the severity of the retinopathy univariate and multivariate analyses were conducted to investigate the relationship of retinopathy with TBC, HbA1c, systolic blood pressure, body mass index, and duration of diabetes. It was shown that serum TBC was significantly higher in patients without retinopathy than in those with retinopathy. Patients with severe retinopathy demonstrated lower TBC, higher systolic blood pressure, and longer diabetes duration. These three parameters were independent explanatory factors for diabetic retinopathy. In conclusion, TBC is lower in patients with type 2 diabetes complicated with severe retinopathy. Thus, it is probable that bilirubin plays protective roles against the onset/ progression of retinopathy in patients with type 2 Diabetes mellitus. Low TBC, high blood pressure, and long diabetes duration are risk factors for diabetic retinopathy.
Masami Tanaka graduated from Tohoku University Medical School, obtaining a medical license. He completed his PhD from Tokyo Women’s Medical University. He worked as a Post doctoral fellow at Vanderbilt University. He is now the Assistant Professor of Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, School of Medicine, Keio University. He has been serving as a Board of Councilors of the Japan Endocrine Society (JES) and as an Editorial Committee of the Journal of Japan Mibyou System Association. He is a Board Certified Endocrinologist and Certified Endocrine Educator of JES. His specialties are diabetes, endocrinology, and hypertension.
Email: tana176k@a7.keio.jp